{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,27]],"date-time":"2025-03-27T08:40:03Z","timestamp":1743064803031,"version":"3.40.3"},"reference-count":64,"publisher":"MJS Publishing, Medical Journals Sweden AB","license":[{"start":{"date-parts":[[2025,3,27]],"date-time":"2025-03-27T00:00:00Z","timestamp":1743033600000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JRM"],"abstract":"<jats:p>Objective: Investigating the role of telerehabilitation in aiding recovery and societal reintegration for COVID-19 survivors, this study aims to identify distinct subphenotypes among survivors and assess their responsiveness to telerehabilitation.\nDesign: A secondary analysis of a multicentre, parallel-group randomized controlled trial from April 2020 through to follow-up in 2021.\nSubjects\/Patients: The study included 377 COVID-19 survivors (47.1% male), with a mean age of 56.4 years.\nMethods: Data from the Telerehabilitation Programme for COVID-19 (TERECO) were analysed using Latent Class Analysis to identify subphenotypes based on baseline characteristics. Clinical outcomes were compared between subphenotypes and treatment groups.\nResults: Latent Class Analysis identified 2 phenotypes: Phenotype 1 (52.9%) characterized by impaired lung function and Phenotype 2 (47.1%) with better lung function. Among those receiving corticosteroids, only Phenotype 1 showed significant benefits from the TERECO intervention. Discrimination accuracy using forced expiratory volume in 1 s (FEV1) and peak expiratory flow was high (AUC = 0.936).\nConclusion: Two distinct phenotypes were identified in COVID-19 survivors, suggesting potential improvements in clinical trial design and personalized treatment strategies based on initial pulmonary function. This insight can guide more targeted rehabilitation approaches, enhancing recovery outcomes for specific survivor groups.<\/jats:p>","DOI":"10.2340\/jrm.v57.42726","type":"journal-article","created":{"date-parts":[[2025,3,27]],"date-time":"2025-03-27T07:32:53Z","timestamp":1743060773000},"page":"jrm42726","source":"Crossref","is-referenced-by-count":0,"title":["Subphenotypic classification of COVID-19 survivors and response to telerehabilitation: a latent class analysis"],"prefix":"10.2340","volume":"57","author":[{"given":"Yide","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qianqian","family":"Xue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zheng","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fengsen","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1183","published-online":{"date-parts":[[2025,3,27]]},"reference":[{"key":"104757","doi-asserted-by":"crossref","unstructured":"O\u2019Mahoney LL, Routen A, Gillies C, Ekezie W, Welford A, Zhang A, et al. The prevalence and long-term health effects of Long Covid among hospitalised and non-hospitalised populations: a systematic review and meta-analysis. EClinicalMedicine 2023; 55: 101762.","DOI":"10.1016\/j.eclinm.2022.101762"},{"key":"104758","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1016\/j.eclinm.2022.101762","DOI":"10.1016\/j.eclinm.2022.101762"},{"key":"104759","doi-asserted-by":"crossref","unstructured":"Visan I. Long COVID. Nat Immunol 2021; 22: 934\u2013935.","DOI":"10.1038\/s41590-021-00992-4"},{"key":"104760","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1038\/s41590-021-00992-4","DOI":"10.1038\/s41590-021-00992-4"},{"key":"104761","doi-asserted-by":"crossref","unstructured":"Nehme M, Braillard O, Chappuis F, Courvoisier DS, Guessous I. Prevalence of symptoms more than seven months after diagnosis of symptomatic COVID-19 in an outpatient setting. Ann Intern Med 2021; 174: 1252\u20131260.","DOI":"10.7326\/M21-0878"},{"key":"104762","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.7326\/M21-0878","DOI":"10.7326\/M21-0878"},{"key":"104763","doi-asserted-by":"crossref","unstructured":"Regmi B, Friedrich J, J\u00f6rn B, Senol M, Giannoni A, Boentert M, et al. Diaphragm muscle weakness might explain exertional dyspnea 15 months after hospitalization for COVID-19. Am J Respir Crit Care Med 2023; 207: 1012\u20131021.","DOI":"10.1164\/rccm.202206-1243OC"},{"key":"104764","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1164\/rccm.202206-1243OC","DOI":"10.1164\/rccm.202206-1243OC"},{"key":"104765","doi-asserted-by":"crossref","unstructured":"Kostandova N, Schluth C, Arambepola R, Atuhaire F, B\u00e9rub\u00e9 S, Chin T, et al. A systematic review of using population-level human mobility data to understand SARS-CoV-2 transmission. Nat Commun 2024; 15: 10504.","DOI":"10.1038\/s41467-024-54895-7"},{"key":"104766","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1038\/s41467-024-54895-7","DOI":"10.1038\/s41467-024-54895-7"},{"key":"104767","doi-asserted-by":"crossref","unstructured":"Hill NS. In persistent dyspnea after COVID-19 ARDS, exercise training rehabilitation vs. usual PT reduced dyspnea at 90 d. Ann Intern Med 2023; 176: Jc117.","DOI":"10.7326\/J23-0073"},{"key":"104768","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.7326\/J23-0073","DOI":"10.7326\/J23-0073"},{"key":"104769","doi-asserted-by":"crossref","unstructured":"McCarthy B, Casey D, Devane D, Murphy K, Murphy E, Lacasse Y. Pulmonary rehabilitation for chronic obstructive pulmonary disease. Cochrane Database Syst Rev 2015; 2015: Cd003793.","DOI":"10.1002\/14651858.CD003793.pub3"},{"key":"104770","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1002\/14651858.CD003793.pub3","DOI":"10.1002\/14651858.CD003793.pub3"},{"key":"104771","doi-asserted-by":"crossref","unstructured":"Lau HM, Ng GY, Jones AY, Lee EW, Siu EH, Hui DS. A randomised controlled trial of the effectiveness of an exercise training program in patients recovering from severe acute respiratory syndrome. Aust J Physiother 2005; 51: 213\u2013219.","DOI":"10.1016\/S0004-9514(05)70002-7"},{"key":"104772","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1016\/S0004-9514(05)70002-7","DOI":"10.1016\/S0004-9514(05)70002-7"},{"key":"104773","doi-asserted-by":"crossref","unstructured":"Singh SJ, Baldwin MM, Daynes E, Evans RA, Greening NJ, Jenkins RG, et al. Respiratory sequelae of COVID-19: pulmonary and extrapulmonary origins, and approaches to clinical care and rehabilitation. Lancet Respir Med 2023; 11: 709\u2013725.","DOI":"10.1016\/S2213-2600(23)00159-5"},{"key":"104774","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1016\/S2213-2600(23)00159-5","DOI":"10.1016\/S2213-2600(23)00159-5"},{"key":"104775","doi-asserted-by":"crossref","unstructured":"Vieira A, Pinto A, Garcia B, Eid RAC, M\u00f3l CG, Nawa RK. Telerehabilitation improves physical function and reduces dyspnoea in people with COVID-19 and post-COVID-19 conditions: a systematic review. J Physiother 2022; 68: 90\u201398.","DOI":"10.1016\/j.jphys.2022.03.011"},{"key":"104776","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1016\/j.jphys.2022.03.011","DOI":"10.1016\/j.jphys.2022.03.011"},{"key":"104777","doi-asserted-by":"crossref","unstructured":"Sonza A, da Cunha de S\u00e1-Caputo D, Sartorio A, Tamini S, Seixas A, Sanudo B, et al. COVID-19 lockdown and the behavior change on physical exercise, pain and psychological well-being: an international multicentric study. Int J Environ Res Public Health 2021; 18: 3810.","DOI":"10.3390\/ijerph18073810"},{"key":"104778","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.3390\/ijerph18073810","DOI":"10.3390\/ijerph18073810"},{"key":"104779","doi-asserted-by":"crossref","unstructured":"Li J, Xia W, Zhan C, Liu S, Yin Z, Wang J, et al. A telerehabilitation programme in post-discharge COVID-19 patients (TERECO): a randomised controlled trial. Thorax 2022; 77: 697\u2013706.","DOI":"10.1136\/thoraxjnl-2021-217382"},{"key":"104780","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1136\/thoraxjnl-2021-217382","DOI":"10.1136\/thoraxjnl-2021-217382"},{"key":"104781","doi-asserted-by":"crossref","unstructured":"Mori M, Krumholz HM, Allore HG. Using Latent Class Analysis to identify hidden clinical phenotypes. JAMA 2020; 324: 700\u2013701.","DOI":"10.1001\/jama.2020.2278"},{"key":"104782","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1001\/jama.2020.2278","DOI":"10.1001\/jama.2020.2278"},{"key":"104783","doi-asserted-by":"crossref","unstructured":"Dahmer MK, Yang G, Zhang M, Quasney MW, Sapru A, Weeks HM, et al. Identification of phenotypes in paediatric patients with acute respiratory distress syndrome: a latent class analysis. Lancet Respir Med 2022; 10: 289\u2013297.","DOI":"10.1016\/S2213-2600(21)00382-9"},{"key":"104784","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1016\/S2213-2600(21)00382-9","DOI":"10.1016\/S2213-2600(21)00382-9"},{"key":"104785","doi-asserted-by":"crossref","unstructured":"Sinha P, Delucchi KL, Thompson BT, McAuley DF, Matthay MA, Calfee CS. Latent class analysis of ARDS subphenotypes: a secondary analysis of the statins for acutely injured lungs from sepsis (SAILS) study. Intensive Care Med 2018; 44: 1859\u20131869.","DOI":"10.1007\/s00134-018-5378-3"},{"key":"104786","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1007\/s00134-018-5378-3","DOI":"10.1007\/s00134-018-5378-3"},{"key":"104787","doi-asserted-by":"crossref","unstructured":"Men\u00e9ndez R, M\u00e9ndez R, Latorre A, Gonz\u00e1lez-Jim\u00e9nez P, Peces-Barba G, Molina-Molina M, et al. Clustering patients with COVID-19 according to respiratory support requirements, and its impact on short- and long-term outcome (RECOVID study). Pulmonology 2025; 31: 2442175.","DOI":"10.1080\/25310429.2024.2442175"},{"key":"104788","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1080\/25310429.2024.2442175","DOI":"10.1080\/25310429.2024.2442175"},{"key":"104789","doi-asserted-by":"crossref","unstructured":"Melo-Oliveira ME, S\u00e1-Caputo D, Bachur JA, Paineiras-Domingos LL, Sonza A, Lacerda AC, et al. Reported quality of life in countries with cases of COVID19: a systematic review. Expert Rev Respir Med 2021; 15: 213\u2013220.","DOI":"10.1080\/17476348.2021.1826315"},{"key":"104790","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1080\/17476348.2021.1826315","DOI":"10.1080\/17476348.2021.1826315"},{"key":"104791","doi-asserted-by":"crossref","unstructured":"Sa\u00f1udo B, Seixas A, Gloeckl R, Rittweger J, Rawer R, Taiar R, et al. Potential application of whole body vibration exercise for improving the clinical conditions of COVID-19 infected individuals: a narrative review from the World Association of Vibration Exercise Experts (WAVex) Panel. Int J Environ Res Public Health 2020; 17: 3650.","DOI":"10.3390\/ijerph17103650"},{"key":"104792","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.3390\/ijerph17103650","DOI":"10.3390\/ijerph17103650"},{"key":"104793","doi-asserted-by":"crossref","unstructured":"Lo YT, Mendell NR, Rubin DB. Testing the number of components in a normal mixture. Biometrika 2001: 88: 767\u2013778.","DOI":"10.1093\/biomet\/88.3.767"},{"key":"104794","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1093\/biomet\/88.3.767","DOI":"10.1093\/biomet\/88.3.767"},{"key":"104795","doi-asserted-by":"crossref","unstructured":"Schwarz GE. Estimating the dimension of a model. Ann Stat 1978; 6.","DOI":"10.1214\/aos\/1176344136"},{"key":"104796","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1214\/aos\/1176344136","DOI":"10.1214\/aos\/1176344136"},{"key":"104797","doi-asserted-by":"crossref","unstructured":"Nylund KL, Asparouhov T, Muth\u00e9n BO. Deciding on the number of classes in latent class analysis and growth mixture modeling: a Monte Carlo simulation study. Struct Equ Modeling 2007; 14: 535\u2013569.","DOI":"10.1080\/10705510701575396"},{"key":"104798","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1080\/10705510701575396","DOI":"10.1080\/10705510701575396"},{"key":"104799","doi-asserted-by":"crossref","unstructured":"Li P, Stuart EA, Allison DB. Multiple imputation: a flexible tool for handling missing data. JAMA 2015; 314: 1966\u20131967.","DOI":"10.1001\/jama.2015.15281"},{"key":"104800","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1001\/jama.2015.15281","DOI":"10.1001\/jama.2015.15281"},{"key":"104801","doi-asserted-by":"crossref","unstructured":"Balachandran VP, Gonen M, Smith JJ, DeMatteo RP. Nomograms in oncology: more than meets the eye. Lancet Oncol 2015; 16: e173\u2013180.","DOI":"10.1016\/S1470-2045(14)71116-7"},{"key":"104802","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1016\/S1470-2045(14)71116-7","DOI":"10.1016\/S1470-2045(14)71116-7"},{"key":"104803","doi-asserted-by":"crossref","unstructured":"Mandrekar JN. Receiver operating characteristic curve in diagnostic test assessment. J Thorac Oncol 2010; 5: 1315\u20131316.","DOI":"10.1097\/JTO.0b013e3181ec173d"},{"key":"104804","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1097\/JTO.0b013e3181ec173d","DOI":"10.1097\/JTO.0b013e3181ec173d"},{"key":"104805","doi-asserted-by":"crossref","unstructured":"Sinha P, Calfee CS, Delucchi KL. Practitioner\u2019s guide to latent class analysis: methodological considerations and common pitfalls. Crit Care Med 2021; 49: e63\u2013e79.","DOI":"10.1097\/CCM.0000000000004710"},{"key":"104806","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1097\/CCM.0000000000004710","DOI":"10.1097\/CCM.0000000000004710"},{"key":"104807","doi-asserted-by":"crossref","unstructured":"Rugo HS, Olopade OI, DeMichele A, Yau C, van \u2018t Veer LJ, Buxton MB, et al. Adaptive randomization of veliparib\u2013carboplatin treatment in breast cancer. N Engl J Med 2016; 375: 23\u201334.","DOI":"10.1056\/NEJMoa1513749"},{"key":"104808","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1056\/NEJMoa1513749","DOI":"10.1056\/NEJMoa1513749"},{"key":"104809","doi-asserted-by":"crossref","unstructured":"Guti\u00e9rrez-Guti\u00e9rrez B, Del Toro MD, Borobia AM, Carcas A, Jarr\u00edn I, Yllescas M, et al. Identification and validation of clinical phenotypes with prognostic implications in patients admitted to hospital with COVID-19: a multicentre cohort study. Lancet Infect Dis 2021; 21: 783\u2013792.","DOI":"10.1016\/S1473-3099(21)00019-0"},{"key":"104810","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1016\/S1473-3099(21)00019-0","DOI":"10.1016\/S1473-3099(21)00019-0"},{"key":"104811","doi-asserted-by":"crossref","unstructured":"Azoulay E, Zafrani L, Mirouse A, Lenglin\u00e9 E, Darmon M, Chevret S. Clinical phenotypes of critically ill COVID-19 patients. Intensive Care Med 2020; 46: 1651\u20131652.","DOI":"10.1007\/s00134-020-06120-4"},{"key":"104812","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1007\/s00134-020-06120-4","DOI":"10.1007\/s00134-020-06120-4"},{"key":"104813","doi-asserted-by":"crossref","unstructured":"Nakamura H, Miyagi K, Otsuki M, Higure Y, Nishiyama N, Kinjo T, et al. Serum KL-6 can distinguish between different phenotypes of severe COVID-19. J Med Virol 2021; 93: 158\u2013160.","DOI":"10.1002\/jmv.26268"},{"key":"104814","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1002\/jmv.26268","DOI":"10.1002\/jmv.26268"},{"key":"104815","doi-asserted-by":"crossref","unstructured":"Filippini DFL, Di Gennaro E, van Amstel RBE, Beenen LFM, Grasso S, Pisani L, et al. Latent class analysis of imaging and clinical respiratory parameters from patients with COVID-19-related ARDS identifies recruitment subphenotypes. Crit Care 2022; 26: 363.","DOI":"10.1186\/s13054-022-04251-2"},{"key":"104816","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1186\/s13054-022-04251-2","DOI":"10.1186\/s13054-022-04251-2"},{"key":"104817","doi-asserted-by":"crossref","unstructured":"Bos LDJ, Sjoding M, Sinha P, Bhavani SV, Lyons PG, Bewley AF, et al. Longitudinal respiratory subphenotypes in patients with COVID-19-related acute respiratory distress syndrome: results from three observational cohorts. Lancet Respir Med 2021; 9: 1377\u20131386.","DOI":"10.1016\/S2213-2600(21)00365-9"},{"key":"104818","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1016\/S2213-2600(21)00365-9","DOI":"10.1016\/S2213-2600(21)00365-9"},{"key":"104819","doi-asserted-by":"crossref","unstructured":"RECOVERY Collaborative Group. Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial. Lancet 2023; 401: 1499\u20131507.","DOI":"10.1016\/S0140-6736(23)00510-X"},{"key":"104820","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1016\/S0140-6736(23)00510-X","DOI":"10.1016\/S0140-6736(23)00510-X"}],"container-title":["Journal of Rehabilitation Medicine"],"original-title":[],"link":[{"URL":"https:\/\/medicaljournalssweden.se\/jrm\/article\/download\/42726\/49636","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/medicaljournalssweden.se\/jrm\/article\/download\/42726\/49636","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,27]],"date-time":"2025-03-27T07:33:43Z","timestamp":1743060823000},"score":1,"resource":{"primary":{"URL":"https:\/\/medicaljournalssweden.se\/jrm\/article\/view\/42726"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,27]]},"references-count":64,"URL":"https:\/\/doi.org\/10.2340\/jrm.v57.42726","relation":{},"ISSN":["1651-2081"],"issn-type":[{"value":"1651-2081","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,27]]}}}